Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Residues at Positions 206 and 209 of the α1 Subunit of γ-Aminobutyric AcidA Receptors Influence Affinities for Benzodiazepine Binding Site Ligands

Andreas Buhr, Martin T. Schaerer, Roland Baur and Erwin Sigel
Molecular Pharmacology October 1997, 52 (4) 676-682; DOI: https://doi.org/10.1124/mol.52.4.676
Andreas Buhr
Department of Pharmacology, University of Bern, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin T. Schaerer
Department of Pharmacology, University of Bern, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Baur
Department of Pharmacology, University of Bern, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erwin Sigel
Department of Pharmacology, University of Bern, CH-3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Ligands of the benzodiazepine binding site allosterically modulate γ-aminobutyric acidA receptors. Their binding pocket is made up of amino acid residues located on both α and γ subunits. We transiently expressed wild-type α1β2γ2 and mutant GABAA receptors in human embryonic kidney 293 cells and determined their binding properties. Receptors containing the mutant αY209A showed ∼40-fold decrease in affinity for [3H]Ro 15–1788 and diazepam, whereas zolpidem displayed no measurable affinity. Receptors containing the mutant αY209F showed a small-to-moderate decrease in affinity for [3H]Ro 15–1788, diazepam, zolpidem, methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate, and Cl 218872, amounting to 2–8-fold. Receptors containing the mutant αY209Q appeared in the surface membrane of transfected cells, bound [3H]muscimol with wild-type affinity, but failed to bind [3H]Ro 15–1788 or [3H]flunitrazepam with detectable affinity. If these mutant receptors were expressed inXenopus laevis oocytes, the apparent affinity for GABA was only slightly decreased, whereas the ability of the currents to be stimulated by low concentrations of flunitrazepam was abolished. Receptors containing a point mutant of another amino acid residue, αT206A, surprisingly showed an increase in affinity of 5- and 16-fold, for the negative allosteric modulator methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate and the partial positive allosteric modulator Cl 218872, respectively, whereas there was only a small decrease in affinity for Ro 15–1788, diazepam, and zolpidem, amounting to 2-, 4-, and 5-fold. Both α206 and α209 are thus both important in determining the binding affinities for ligands of the benzodiazepine binding site. The residues are spaced at an interval of three amino acids and may be part of an α helix.

Footnotes

    • Received April 21, 1997.
    • Accepted June 20, 1997.
  • Send reprint requests to: Dr. Erwin Sigel, Department of Pharmacology, University of Bern, Friedbühlstr. 49, CH-3010 Bern, Switzerland. E-mail:sigel{at}pki.unibe.ch

  • This work was supported by Grant 31–37192.93 from the Swiss National Science Foundation, EU Grant BIO4-CT96–0585 (BWW 96.0010), and the Foundation for the Promotion of Scientific Research at the University of Bern.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (4)
Molecular Pharmacology
Vol. 52, Issue 4
1 Oct 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Residues at Positions 206 and 209 of the α1 Subunit of γ-Aminobutyric AcidA Receptors Influence Affinities for Benzodiazepine Binding Site Ligands
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Residues at Positions 206 and 209 of the α1 Subunit of γ-Aminobutyric AcidA Receptors Influence Affinities for Benzodiazepine Binding Site Ligands

Andreas Buhr, Martin T. Schaerer, Roland Baur and Erwin Sigel
Molecular Pharmacology October 1, 1997, 52 (4) 676-682; DOI: https://doi.org/10.1124/mol.52.4.676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Residues at Positions 206 and 209 of the α1 Subunit of γ-Aminobutyric AcidA Receptors Influence Affinities for Benzodiazepine Binding Site Ligands

Andreas Buhr, Martin T. Schaerer, Roland Baur and Erwin Sigel
Molecular Pharmacology October 1, 1997, 52 (4) 676-682; DOI: https://doi.org/10.1124/mol.52.4.676
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics